New adamantyl comprising tripeptides, derivatives and hydrochlor

Details New adamantyl comprising tripeptides, derivatives and hydrochlor New adamantyl comprising tripeptides, derivatives and hydrochlor

1991-11-15

1994-02-15

Wityshyn, Michael G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530331, A61K 3702, C07K 508

Patent

active

052867153

ABSTRACT:
2-Adamantyl- and 1-adamantyl-D/L-glycyl-L-alanyl-D-isoglutamine and their derivatives of the formulae ##STR1## wherein R stands for a hydrogen atom or a MurNAc group, and hydrochlorides thereof, a process for the preparation thereof and their use to obtain pharmaceuticals, which are particularly indicated for the treatment of viral diseases and tumors and/or immunomodulations in humans and animals.

REFERENCES:
patent: 3705141 (1972-12-01), Krimmel
patent: 5066642 (1991-11-01), Vransic et al.

Affiliated with

Also associated with

Rating

New adamantyl comprising tripeptides, derivatives and hydrochlor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New adamantyl comprising tripeptides, derivatives and hydrochlor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New adamantyl comprising tripeptides, derivatives and hydrochlor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1207100